Rodman David Malcom (CIK 1672659) reported 96 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-17). Recent activity: Buy MLYS (3,542 shares), Sell MLYS (9,890 shares), Buy MLYS (4,167 shares), Buy MLYS (417 shares), Sell MLYS (4,584 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 3,542 | $36,128 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 9,890 | $235,487 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 4,167 | $59,380 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 417 | $6,438 |
| 2026-06-17 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 4,584 | $114,600 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 2,170 | $34,720 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 2,170 | $54,250 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 6,349 | $6,857 |
| 2026-06-12 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 6,349 | $151,901 |
| 2026-05-19 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 417 | $6,438 |
| 2026-05-19 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 417 | $11,488 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 2,171 | $64,500 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 6,348 | $6,856 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 6,348 | $186,348 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 3,541 | $36,118 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 4,166 | $59,366 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 14,056 | $401,789 |
| 2026-05-13 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 2,171 | $34,736 |
| 2026-04-21 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 416 | $6,423 |
| 2026-04-21 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 416 | $13,033 |
| 2026-04-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 6,348 | $175,586 |
| 2026-04-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 6,349 | $6,857 |
| 2026-04-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 3,542 | $36,128 |
| 2026-04-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Buy | 4,167 | $59,380 |
| 2026-04-15 | Mineralys Therapeutics, Inc. (MLYS) | Chief Medical Officer | Sell | 14,058 | $373,087 |
Source: SEC Form 4 filings · as of 2026-06-17